Analysis of euploidy rates in preimplantation genetic testing for aneuploidy cycles with progestin-primed versus GnRH agonist/antagonist protocol

Lu Wang,Jingyun Wang,Yuan Zhang,Chen Qian,Xiaohui Wang,Jie Bai,Fang Li,Zhiqin Chen,Ai Ai
DOI: https://doi.org/10.1186/s40001-023-01000-1
IF: 4.981
2023-01-16
European Journal of Medical Research
Abstract:Progestins can suppress endogenous luteinising hormone (LH) secretion from the pituitary gland and have shown similar efficacy in terms of collecting competent oocytes and embryos; however, some inconsistencies have been proposed regarding the quality of embryos collected with the use of progestins. This study aimed to evaluate euploidy rates and pregnancy outcomes in preimplantation genetic testing for aneuploidy (PGT-A) cycles using the progestin-primed ovarian stimulation (PPOS) protocol versus the gonadotropin-releasing hormone (GnRH) agonist/antagonist protocol.
medicine, research & experimental
What problem does this paper attempt to address?